Moreover, studies have shown that treatment with exogenous IL-2 or Ab/IL-2 can selectively expand Tregs, improve immune regulation, and prevent or reverse disease at the onset of diabetes in NOD mice [5,6,10,11]. Here, IL2 is linked to diabetes mellitus.